In October 2023 the Anti-Doping Agency of Kenya (ADAK) reported an anti-doping rule violation against the Athlete Rosemary Chelangat after her sample tested positive for the prohibited substance Erythropoietin (EPO).
Following notification ADAK was unable to locate the Athlete and she failed to respond. Thereupon the case was referred to the Kenya Sports Disputes Tribunal and a decision was rendered based on the written submissions of the Parties.
In view of the evidence the Panel finds that the presence of a prohibited substance has been established in the Athlete's sample and accordingly that she committed an anti-doping rule violation.
Without the Athlete's response the Panel deems that she failed to demonstrate that the violation was not intentional, nor how the substance had entered her system. Furthermore the Panel finds that there are no grounds for a reduced sanction.
Therefore the Panel decides on 25 April 2024 to impose a 4 year period of ineligibility on the Athlete, starting on the date of the provisional suspension, i.e. on 29 October 2023.
